If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

APLS Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 8.00%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $19,150,427.47

Apellis Pharmaceuticals Insider Trading History Chart

Apellis Pharmaceuticals Share Price & Price History

^$62.76

▼ -0.29 (-0.46%)

As of 03/21/2023 04:33 PM ET

Days: 30 | 90 | 365

Stocks Positioned For The Year

From PressReach | Ad

This breakthrough stock has bright future this decade.

Learn more today.

Apellis Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/8/2023	Pascal Deschatelets	Insider	Sell	12,000	$63.79	$765,480.00	1,020,813
2/23/2023	Jeffrey Eisele	Insider	Sell	1,646	$68.76	$113,178.96	53,883
2/8/2023	Pascal Deschatelets	Insider	Sell	12,000	$54.45	$653,400.00	1,006,756
2/3/2023	Adam J. Townsend	Insider	Sell	5,000	$55.85	$279,250.00	67,932
1/30/2023	Jeffrey Eisele	Insider	Sell	883	$52.76	$46,587.08	46,468
1/23/2023	Karen Lewis	Insider	Sell	2,955	$51.58	$152,418.90	37,709
1/17/2023	Alec Machiels	Director	Sell	1,250	$52.42	$65,525.00	267,641
1/9/2023	Pascal Deschatelets	Insider	Sell	12,000	$46.08	$552,960.00	983,780
1/5/2023	Federico Grossi	Insider	Sell	2,500	$48.79	$121,975.00	94,884
1/3/2023	A. Sinclair Dunlop	Director	Sell	500	$50.70	$25,350.00	132,797
1/3/2023	Adam J. Townsend	Insider	Sell	5,000	$50.70	$253,500.00	42,907
12/19/2022	Cedric Francois	CEO	Sell	28,200	$52.06	$1,468,092.00	965,128
12/15/2022	Alec Machiels	Director	Sell	1,250	$52.35	$65,437.50	263,774
12/8/2022	Pascal Deschatelets	Insider	Sell	12,000	$47.50	$570,000.00	970,280
12/5/2022	Adam J. Townsend	Insider	Sell	5,000	$50.38	$251,900.00	42,907
12/1/2022	A. Sinclair Dunlop	Director	Sell	500	$49.93	$24,965.00	129,430
12/1/2022	Federico Grossi	Insider	Sell	2,500	$49.93	$124,825.00	97,384
11/8/2022	Pascal Deschatelets	Insider	Sell	12,000	$46.47	$557,640.00	963,780
11/3/2022	Adam J. Townsend	Insider	Sell	5,000	$58.54	$292,700.00	42,907
10/14/2022	Alec Machiels	Director	Sell	1,250	$59.31	$74,137.50	263,774
10/10/2022	Pascal Deschatelets	Insider	Sell	12,000	$57.50	$690,000.00	957,280
10/3/2022	Federico Grossi	Insider	Sell	2,500	$66.69	$166,725.00	102,384
9/15/2022	Alec Machiels	Director	Sell	1,250	$66.00	$82,500.00	263,774
9/8/2022	Pascal Deschatelets	Insider	Sell	12,000	$63.98	$767,760.00	950,780
8/17/2022	Mark Jeffrey DeLong	SVP	Sell	5,000	$69.50	$347,500.00	29,250
8/15/2022	Adam J. Townsend	Insider	Sell	12,500	$69.00	$862,500.00	42,907
8/15/2022	Alec Machiels	Director	Sell	1,250	$67.21	$84,012.50	263,774
8/11/2022	A. Sinclair Dunlop	Director	Sell	30,000	$65.63	$1,968,900.00	255,679
8/11/2022	Adam J. Townsend	Insider	Sell	12,500	$67.00	$837,500.00	42,907
8/11/2022	Mark Jeffrey DeLong	SVP	Sell	5,000	$67.00	$335,000.00	29,250
8/3/2022	Adam J. Townsend	Insider	Sell	5,000	$56.43	$282,150.00	37,907
8/1/2022	Federico Grossi	Insider	Sell	2,500	$55.99	$139,975.00	107,384
7/27/2022	Mark Jeffrey DeLong	SVP	Sell	5,000	$57.00	$285,000.00	29,250
7/19/2022	Mark Jeffrey DeLong	SVP	Sell	5,000	$56.42	$282,100.00	29,250
7/15/2022	Alec Machiels	Director	Sell	1,250	$46.33	$57,912.50	263,774
7/11/2022	Adam J. Townsend	Insider	Sell	5,000	$48.42	$242,100.00	42,907
7/8/2022	Pascal Deschatelets	Insider	Sell	12,000	$47.95	$575,400.00	937,780
6/27/2022	A. Sinclair Dunlop	Director	Sell	1,341	$46.79	$62,745.39	1,341
6/23/2022	A. Sinclair Dunlop	Director	Sell	15,000	$45.00	$675,000.00	285,679
6/22/2022	David O. Watson	General Counsel	Sell	10,000	$44.51	$445,100.00	115,569
6/17/2022	Victoria L Brown	Insider	Sell	2,698	$45.00	$121,410.00	24,974
6/16/2022	Mark Jeffrey DeLong	SVP	Sell	10,000	$41.78	$417,800.00	29,250
6/15/2022	Alec Machiels	Director	Sell	1,250	$39.29	$49,112.50	263,774
6/8/2022	Pascal Deschatelets	Insider	Sell	12,000	$44.09	$529,080.00	891,775
6/1/2022	Federico Grossi	Insider	Sell	2,500	$41.78	$104,450.00	109,561
5/27/2022	Lukas Scheibler	Insider	Sell	10,000	$43.00	$430,000.00	40,358
5/16/2022	Alec Machiels	Director	Sell	1,250	$39.18	$48,975.00	263,774
5/2/2022	Federico Grossi	Insider	Sell	2,500	$43.56	$108,900.00	112,061
4/29/2022	Pascal Deschatelets	Insider	Sell	4,000	$44.43	$177,720.00	891,775
4/25/2022	David O. Watson	General Counsel	Sell	5,000	$50.00	$250,000.00	125,569
4/20/2022	Mark Jeffrey DeLong	SVP	Sell	7,000	$52.53	$367,710.00	28,481
4/14/2022	Alec Machiels	Director	Sell	1,250	$50.90	$63,625.00	263,774
4/4/2022	Lukas Scheibler	Insider	Sell	3,504	$56.96	$199,587.84	52,233
4/1/2022	Lukas Scheibler	Insider	Sell	11,496	$55.05	$632,854.80	52,233
3/15/2022	Alec Machiels	Director	Sell	1,250	$39.57	$49,462.50
3/15/2022	Federico Grossi	Insider	Sell	375	$39.57	$14,838.75
2/15/2022	Alec Machiels	Director	Sell	1,250	$45.43	$56,787.50
2/15/2022	Federico Grossi	Insider	Sell	375	$45.43	$17,036.25
2/11/2022	Lukas Scheibler	Insider	Sell	1,666	$46.80	$77,968.80
2/8/2022	Lukas Scheibler	Insider	Sell	10,000	$45.00	$450,000.00
1/31/2022	Lukas Scheibler	Insider	Sell	1,233	$38.47	$47,433.51
1/14/2022	Alec Machiels	Director	Sell	1,250	$40.56	$50,700.00
1/14/2022	Federico Grossi	Insider	Sell	375	$40.56	$15,210.00
12/27/2021	David O. Watson	General Counsel	Sell	1,200	$48.50	$58,200.00
12/22/2021	David O. Watson	General Counsel	Sell	10,571	$47.81	$505,399.51
11/18/2021	Morningside Venture Investment	Major Shareholder	Buy	250,000	$40.00	$10,000,000.00
11/1/2021	Federico Grossi	Insider	Sell	625	$30.70	$19,187.50
10/14/2021	Federico Grossi	Insider	Sell	750	$34.57	$25,927.50
7/21/2021	Mark Jeffrey DeLong	SVP	Sell	1,000	$65.00	$65,000.00	10,490
7/15/2021	Alec Machiels	Director	Sell	2,500	$62.30	$155,750.00	672,044
7/15/2021	Mark Jeffrey DeLong	SVP	Sell	1,000	$62.30	$62,300.00	10,490
7/14/2021	Federico Grossi	Insider	Sell	500	$64.68	$32,340.00
7/8/2021	Federico Grossi	Insider	Sell	250	$65.68	$16,420.00	63,680
6/24/2021	Pascal Deschatelets	Insider	Sell	6,250	$65.61	$410,062.50	875,837
6/15/2021	Alec Machiels	Director	Sell	2,500	$64.83	$162,075.00	672,044
6/15/2021	Mark Jeffrey DeLong	SVP	Sell	4,000	$64.96	$259,840.00	13,490
6/14/2021	Federico Grossi	Insider	Sell	500	$61.84	$30,920.00	54,930
6/11/2021	Nicole D Perry	VP	Sell	1,000	$61.55	$61,550.00	5,847
6/10/2021	Lukas Scheibler	Insider	Sell	3,417	$60.00	$205,020.00
6/1/2021	Nicole D Perry	VP	Sell	1,000	$56.40	$56,400.00	5,847
5/20/2021	A. Sinclair Dunlop	Director	Sell	5,773	$48.10	$277,681.30
5/18/2021	A. Sinclair Dunlop	Director	Sell	149,488	$52.85	$7,900,440.80
5/18/2021	Mark Jeffrey DeLong	SVP	Sell	2,000	$55.00	$110,000.00
4/30/2021	Nicole D Perry	VP	Sell	1,000	$50.00	$50,000.00	5,847
4/23/2021	Pascal Deschatelets	Insider	Sell	6,250	$46.13	$288,312.50	871,337
4/21/2021	Alec Machiels	Director	Sell	2,500	$45.76	$114,400.00	672,044
4/14/2021	Federico Grossi	Insider	Sell	500	$42.82	$21,410.00	56,214
4/1/2021	Federico Grossi	Insider	Sell	600	$43.41	$26,046.00	56,714
3/15/2021	Alec Machiels	Director	Sell	2,500	$46.77	$116,925.00	672,044
3/15/2021	Federico Grossi	Insider	Sell	500	$46.77	$23,385.00	57,314
3/10/2021	Pascal Deschatelets	Insider	Sell	6,250	$50.74	$317,125.00
3/5/2021	Federico Grossi	Insider	Sell	5,000	$48.62	$243,100.00	62,814
2/9/2021	Nicole D Perry	VP	Sell	2,000	$50.00	$100,000.00	4,500
1/15/2021	Alec Machiels	Director	Sell	2,500	$53.15	$132,875.00	672,044
1/14/2021	Federico Grossi	Insider	Sell	4,000	$51.99	$207,960.00	35,827
12/15/2020	Cedric Francois	CEO	Sell	5,000	$52.16	$260,800.00	1,113,079
12/14/2020	A. Sinclair Dunlop	Director	Sell	25,000	$54.67	$1,366,750.00	672,044
12/14/2020	David O. Watson	General Counsel	Sell	18,333	$50.94	$933,883.02
12/7/2020	A. Sinclair Dunlop	Director	Sell	25,000	$50.59	$1,264,750.00
12/4/2020	A. Sinclair Dunlop	Director	Sell	6,436	$50.26	$323,473.36
12/4/2020	Nicole D Perry	VP	Sell	18,000	$50.00	$900,000.00	18,000
12/1/2020	Federico Grossi	Insider	Sell	600	$48.25	$28,950.00
11/16/2020	Alec Machiels	Director	Sell	2,500	$39.38	$98,450.00	672,044
11/16/2020	Cedric Francois	CEO	Sell	5,000	$39.38	$196,900.00	1,078,079
11/2/2020	Federico Grossi	Insider	Sell	600	$31.09	$18,654.00	27,725
10/15/2020	Alec Machiels	Director	Sell	2,500	$35.00	$87,500.00	672,044
10/15/2020	Cedric Francois	CEO	Sell	5,000	$34.46	$172,300.00	1,083,079
10/7/2020	Alec Machiels	Director	Sell	7,500	$35.00	$262,500.00	677,044
10/7/2020	Victoria L. Brown	Insider	Sell	12,000	$35.00	$420,000.00
9/15/2020	Cedric Francois	CEO	Sell	5,000	$30.96	$154,800.00
9/1/2020	Federico Grossi	Insider	Sell	600	$31.58	$18,948.00	28,925
8/20/2020	Cedric Francois	CEO	Sell	3,457	$30.00	$103,710.00	1,093,079
8/18/2020	Cedric Francois	CEO	Sell	1,543	$30.00	$46,290.00	1,096,536
8/3/2020	Federico Grossi	Insider	Sell	600	$26.28	$15,768.00	29,525
7/15/2020	Cedric Francois	CEO	Sell	5,000	$32.12	$160,600.00	1,098,079
7/1/2020	Federico Grossi	Insider	Sell	850	$32.43	$27,565.50	30,125
6/15/2020	Alec Machiels	Director	Sell	2,500	$30.21	$75,525.00
6/15/2020	Cedric Francois	CEO	Sell	5,000	$30.21	$151,050.00

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

SEC Filings (Institutional Ownership Changes) for Apellis Pharmaceuticals (NASDAQ:APLS)

87.26% of Apellis Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Apellis Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/10/2023	Victory Capital Management Inc.	430,551	$22.26M	0.0%	-36.0%	0.387%
2/28/2023	Voya Investment Management LLC	158,077	$8.17M	0.0%	-4.4%	0.142%
2/24/2023	Natixis	345,000	$17.84M	0.1%	+22.3%	0.310%
2/22/2023	Teachers Retirement System of The State of Kentucky	78,486	$4.06M	0.0%	-24.4%	0.071%
2/21/2023	Macquarie Group Ltd.	1,461,642	$75.58M	0.1%	+2.8%	1.322%
2/16/2023	Alliancebernstein L.P.	111,100	$5.75M	0.0%	-27.3%	0.100%
2/15/2023	Pier Capital LLC	75,217	$3.89M	0.6%	+35.8%	0.068%
2/15/2023	State of Wisconsin Investment Board	88,158	$4.56M	0.0%	+8.6%	0.080%
2/15/2023	Schonfeld Strategic Advisors LLC	16,400	$0.85M	0.0%	-80.6%	0.015%
2/15/2023	Stelac Advisory Services LLC	5,520	$0.29M	0.1%	N/A	0.005%
2/15/2023	T. Rowe Price Investment Management Inc.	5,842,660	$302.12M	0.2%	+5.9%	5.284%
2/15/2023	Legal & General Group Plc	80,394	$4.16M	0.0%	-0.3%	0.073%
2/15/2023	Lombard Odier Asset Management Switzerland SA	170,353	$8.81M	0.7%	+31.5%	0.154%
2/15/2023	Mackenzie Financial Corp	10,302	$0.53M	0.0%	-77.7%	0.009%
2/15/2023	Millennium Management LLC	19,636	$1.02M	0.0%	-89.0%	0.018%
2/15/2023	Morgan Stanley	299,883	$15.51M	0.0%	+34.3%	0.271%
2/15/2023	Man Group plc	105,784	$5.47M	0.0%	-26.2%	0.096%
2/15/2023	Nomura Holdings Inc.	59,465	$3.07M	0.0%	-19.1%	0.054%
2/15/2023	Norges Bank	1,047,454	$54.16M	0.0%	N/A	0.947%
2/15/2023	E Fund Management Co. Ltd.	8,604	$0.45M	0.0%	+22.0%	0.008%
2/15/2023	Eagle Asset Management Inc.	136,114	$6.84M	0.0%	-3.6%	0.123%
2/15/2023	Eversept Partners LP	154,796	$8.01M	0.7%	N/A	0.140%
2/15/2023	Fred Alger Management LLC	206,263	$10.67M	0.1%	+53.6%	0.187%
2/15/2023	AQR Capital Management LLC	17,191	$0.89M	0.0%	+104.7%	0.016%
2/15/2023	Avoro Capital Advisors LLC	10,625,000	$549.42M	8.2%	+4.9%	9.608%
2/15/2023	Braidwell LP	389,596	$20.15M	0.7%	N/A	0.352%
2/14/2023	Boxer Capital LLC	1,576,000	$81.50M	4.3%	+20.9%	1.425%
2/14/2023	Price T Rowe Associates Inc. MD	2,749,542	$142.18M	0.0%	-17.9%	2.486%
2/14/2023	Moore Capital Management LP	10,000	$0.52M	0.0%	-94.4%	0.009%
2/14/2023	Putnam Investments LLC	97,560	$5.05M	0.0%	-7.8%	0.088%
2/14/2023	Amundi	25,838	$1.29M	0.0%	-15.0%	0.023%
2/14/2023	683 Capital Management LLC	175,000	$9.05M	0.8%	N/A	0.158%
2/14/2023	Nelson Van Denburg & Campbell Wealth Management Group LLC	3,382	$0.18M	0.0%	N/A	0.003%
2/14/2023	Marshall Wace LLP	436,423	$22.57M	0.1%	+29.6%	0.395%
2/14/2023	Granahan Investment Management LLC	182,508	$9.44M	0.3%	+33.5%	0.165%
2/14/2023	Driehaus Capital Management LLC	293,545	$15.18M	0.2%	-65.8%	0.265%
2/13/2023	Charles Schwab Investment Management Inc.	982,927	$50.83M	0.0%	+3.6%	0.889%
2/13/2023	Deutsche Bank AG	263,177	$13.61M	0.0%	-53.6%	0.238%
2/13/2023	Baird Financial Group Inc.	39,477	$2.04M	0.0%	+23.6%	0.036%
2/13/2023	Panagora Asset Management Inc.	16,231	$0.84M	0.0%	-19.4%	0.015%
2/13/2023	Natixis	243,000	$12.57M	0.0%	-13.8%	0.220%
2/13/2023	Boulder Hill Capital Management LP	7,100	$0.37M	0.3%	N/A	0.006%
2/13/2023	Barclays PLC	227,347	$11.76M	0.0%	+70.7%	0.206%
2/13/2023	Renaissance Technologies LLC	187,413	$9.69M	0.0%	-45.7%	0.169%
2/13/2023	The Manufacturers Life Insurance Company	82,830	$4.28M	0.0%	-11.0%	0.075%
2/13/2023	ExodusPoint Capital Management LP	14,792	$0.77M	0.0%	N/A	0.013%
2/13/2023	Picton Mahoney Asset Management	33,526	$1.73M	0.1%	+8.7%	0.030%
2/13/2023	Neuberger Berman Group LLC	55,498	$2.87M	0.0%	+25.2%	0.050%
2/13/2023	Geode Capital Management LLC	1,750,001	$90.49M	0.0%	+3.5%	1.583%
2/13/2023	Finepoint Capital LP	334,890	$17.32M	5.6%	+25.9%	0.303%
2/13/2023	American Century Companies Inc.	230,824	$11.94M	0.0%	+1,411.5%	0.209%
2/13/2023	Capital Fund Management S.A.	12,884	$0.67M	0.0%	N/A	0.012%
2/13/2023	Artal Group S.A.	900,000	$46.54M	2.6%	-10.0%	0.814%
2/13/2023	Rhenman & Partners Asset Management AB	200,000	$10.34M	1.1%	-9.1%	0.181%
2/13/2023	Teacher Retirement System of Texas	27,002	$1.40M	0.0%	-3.1%	0.024%
2/10/2023	Bank of America Corp DE	469,012	$24.25M	0.0%	-32.2%	0.424%
2/10/2023	Creative Planning	14,087	$0.73M	0.0%	+132.0%	0.013%
2/10/2023	Amalgamated Bank	15,403	$0.80M	0.0%	+1.5%	0.014%
2/10/2023	Sei Investments Co.	10,796	$0.56M	0.0%	-80.7%	0.010%
2/10/2023	Connor Clark & Lunn Investment Management Ltd.	76,881	$3.98M	0.0%	+1,346.8%	0.070%
2/10/2023	Sectoral Asset Management Inc.	152,340	$7.88M	1.5%	+22.9%	0.138%
2/10/2023	Victory Capital Management Inc.	430,551	$22.26M	0.0%	-36.0%	0.389%
2/10/2023	Tekla Capital Management LLC	66,426	$3.44M	0.1%	-75.0%	0.060%
2/10/2023	Advisor Group Holdings Inc.	3,249	$0.17M	0.0%	+6.9%	0.003%
2/10/2023	PNC Financial Services Group Inc.	60,955	$3.15M	0.0%	+5.2%	0.055%
2/10/2023	Vanguard Personalized Indexing Management LLC	6,221	$0.32M	0.0%	N/A	0.006%
2/9/2023	Mirae Asset Global Investments Co. Ltd.	45,179	$2.34M	0.0%	+5.3%	0.041%
2/9/2023	First Trust Advisors LP	52,780	$2.73M	0.0%	+109.2%	0.048%
2/9/2023	Jennison Associates LLC	2,515,317	$130.07M	0.1%	-0.8%	2.275%
2/9/2023	Victory Capital Management Inc.	430,458	$22.27M	0.0%	-36.0%	0.389%
2/9/2023	Dimensional Fund Advisors LP	41,007	$2.12M	0.0%	-50.4%	0.037%
2/9/2023	Crown Wealth Group LLC	11,814	$0.61M	0.6%	+137.5%	0.011%
2/9/2023	Principal Financial Group Inc.	72,982	$3.77M	0.0%	+191.4%	0.066%
2/9/2023	Axiom Investors LLC DE	25,348	$1.31M	0.0%	-20.7%	0.023%
2/9/2023	Saturn V Capital Management LLC	212,329	$9.41M	7.8%	N/A	0.192%
2/9/2023	HC Advisors LLC	5,725	$0.30M	0.2%	-86.2%	0.005%
2/8/2023	Raymond James Financial Services Advisors Inc.	11,418	$0.59M	0.0%	-2.2%	0.010%
2/8/2023	Raymond James & Associates	14,437	$0.75M	0.0%	+2.9%	0.013%
2/8/2023	UBS Group AG	131,897	$6.82M	0.0%	+337.6%	0.119%
2/8/2023	Skandinaviska Enskilda Banken AB publ	30,846	$1.60M	0.0%	-16.8%	0.028%
2/8/2023	California Public Employees Retirement System	191,964	$9.93M	0.0%	+13.1%	0.174%
2/8/2023	Swiss National Bank	212,200	$10.97M	0.0%	+5.0%	0.192%
2/8/2023	Russell Investments Group Ltd.	71,875	$3.72M	0.0%	-18.5%	0.065%
2/8/2023	Arizona State Retirement System	24,801	$1.28M	0.0%	+7.1%	0.022%
2/7/2023	Duality Advisers LP	11,823	$0.61M	0.1%	-68.9%	0.011%
2/7/2023	Bleakley Financial Group LLC	182,438	$9.43M	0.3%	N/A	0.165%
2/7/2023	Handelsbanken Fonder AB	12,000	$0.62M	0.0%	+2.6%	0.011%
2/7/2023	TD Asset Management Inc	271,620	$14.05M	0.0%	-2.5%	0.246%
2/6/2023	Banque Pictet & Cie SA	158,925	$8.22M	0.1%	-5.9%	0.144%
2/6/2023	Lisanti Capital Growth LLC	55,695	$2.88M	0.4%	-71.8%	0.050%
2/3/2023	EFG Asset Management North America Corp.	25,377	$1.31M	0.3%	-7.2%	0.023%
2/3/2023	Illinois Municipal Retirement Fund	8,694	$0.45M	0.0%	N/A	0.008%
2/2/2023	SG Americas Securities LLC	31,382	$1.62M	0.0%	+12.6%	0.028%
2/2/2023	ProShare Advisors LLC	22,637	$1.17M	0.0%	+7.4%	0.020%
2/2/2023	Profund Advisors LLC	12,722	$0.66M	0.0%	+2.5%	0.012%
2/2/2023	Stock Yards Bank & Trust Co.	11,215	$0.58M	0.0%	+18.1%	0.010%
2/1/2023	Bank of Montreal Can	100,931	$5.22M	0.0%	-22.0%	0.091%
2/1/2023	State of New Jersey Common Pension Fund D	57,903	$2.99M	0.0%	+5.6%	0.052%
2/1/2023	Zurcher Kantonalbank Zurich Cantonalbank	10,635	$0.55M	0.0%	-7.6%	0.010%
2/1/2023	Legato Capital Management LLC	6,961	$0.36M	0.1%	N/A	0.006%

Data available starting January 2016

Apellis Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, and Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.

Today's Range

Now: $62.76

$62.34

$63.70

50 Day Range

MA: $57.30

$49.02

$66.96

52 Week Range

Now: $62.76

$33.32

$70.75

Volume

900,568 shs

Average Volume

1,700,257 shs

Market Capitalization

$6.98 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.19

Who are the company insiders with the largest holdings of Apellis Pharmaceuticals?: Apellis Pharmaceuticals' top insider investors include:
Pascal Deschatelets (Insider)
Cedric Francois (CEO)
Alec Machiels (Director)
A Sinclair Dunlop (Director)
David O Watson (General Counsel)
Federico Grossi (Insider)
Adam J Townsend (Insider)
Jeffrey Eisele (Insider)
Lukas Scheibler (Insider)
Karen Lewis (Insider)
Mark Jeffrey Delong (SVP)
Victoria L Brown (Insider)
Nicole D Perry (VP)
Morningside Venture Investment (Major Shareholder)
Learn More about top insider investors at Apellis Pharmaceuticals.
Who are the major institutional investors of Apellis Pharmaceuticals?: Apellis Pharmaceuticals' top institutional shareholders include:
Avoro Capital Advisors LLC — 9.61%
T. Rowe Price Investment Management Inc. — 5.28%
Price T Rowe Associates Inc. MD — 2.49%
Jennison Associates LLC — 2.27%
Geode Capital Management LLC — 1.58%
Boxer Capital LLC — 1.43%
Learn More about top institutional investors of Apellis Pharmaceuticals stock.
Which institutional investors are selling Apellis Pharmaceuticals stock?: Within the last quarter, APLS stock was sold by these institutional investors:
Price T Rowe Associates Inc. MD
Driehaus Capital Management LLC
Assenagon Asset Management S.A.
Deutsche Bank AG
Victory Capital Management Inc.
Victory Capital Management Inc.
Victory Capital Management Inc.
Bank of America Corp DE
In the last year, company insiders that have sold Apellis Pharmaceuticals company stock include:
Pascal Deschatelets (Insider)
Cedric Francois (CEO)
Alec Machiels (Director)
A Sinclair Dunlop (Director)
David O Watson (General Counsel)
Federico Grossi (Insider)
Adam J Townsend (Insider)
Jeffrey Eisele (Insider)
Lukas Scheibler (Insider)
Karen Lewis (Insider)
Mark Jeffrey Delong (SVP)
Victoria L Brown (Insider)
Learn More investors selling Apellis Pharmaceuticals stock.
Which institutional investors are buying Apellis Pharmaceuticals stock?: During the previous quarter, APLS stock was purchased by institutional investors including:
Norges Bank
Avoro Capital Advisors LLC
Braidwell LP
T. Rowe Price Investment Management Inc.
Boxer Capital LLC
American Century Companies Inc.
Saturn V Capital Management LLC
Bleakley Financial Group LLC